Karo Healthcare

Karo Healthcare owns and commercialises branded everyday healthcare products and medicines, including ACO, E45, Lamisil, Proct, Nutravita, Remescar, Pevaryl, Flux, Multi-Gyn and Paracet. The portfolio covers skin health, foot health, digestive health, intimate health and vitamins and minerals.

The website says its products are sold in more than 90 countries, with Europe and the Nordic region as core markets. It reports revenue of €500+ million, a workforce of approx. 460 colleagues across 13 countries, and 150 new products launched in 2023. Consumers are the end users, and the site points them to pharmacists and general practitioners for product advice.

The company is headquartered in Stockholm, Sweden according to its registry country, and the website names Stockholm among its job locations. The founding year is not stated on the website. Its 16 open roles are in Business to Consumer, Finance & Digital, Transformation & Revenue Growth Management, Operations and Scientific Affairs, located in Stockholm, Düsseldorf, Warsaw, Kaunas, Copenhagen, Espoo and Maidenhead.

Product: Branded over-the-counter and everyday healthcare products and medicines in skin, foot, digestive, intimate health and vitamins and minerals categories.